NEUROLOGIX, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -.--% |
Neurologix, Inc. engages in the research and development of gene transfer therapies for the treatment for brain disorders and central nervous system diseases. The company programs address conditions such as Parkinson's disease, epilepsy, depression and Huntington's disease.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- NRGXQ Stock
